Our results from the Transwell assay showed that the number of cells that migrated or invaded were remarkably lessened in the U251 and U87-MG cells after Chr-A treatment at different concentrations (Figure 3a–d), demonstrating that metastasis and invasiveness of glioblastoma cells were restrained in the presence of Chr-A. Here, HRAS is linked to glioblastoma.